Tag Cancer
Mackie honored as his latest startup shifts toward high gear
Thomas “Rock” Mackie, a scientist, entrepreneur and educator, has been honored with the 2015 Excellence in Entrepreneurial Education award for career-long assistance to students and faculty interested in starting businesses.
Compound doubles up on cancer detection
Tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer, according to a study published last week in the Proceedings of the National Academy of Sciences (PNAS).
Innovative cancer treatment machine: Still made in Wisconsin
Innovator-entrepreneur Thomas “Rock” Mackie’s TomoTherapy, launched in 1997, remains one of the universities’ most successful spinoff companies.
Cancer discovery links experimental vaccine and biological treatment
A new study at the University of Wisconsin–Madison has linked two seemingly unrelated cancer treatments that are both now being tested in clinical trials.
Study redefines role of estrogen in cervical cancer
Scientists have prior evidence that the hormone estrogen is a major driver in the growth of cervical cancer, but a new study examining genetic profiles of 128 clinical cases reached a surprising conclusion: Estrogen receptors all but vanish in cervical cancer tumors.
Navigating multiple myeloma with ‘Google Maps’ for the cancer genome
In some ways, studying the genetics of cancer has been like examining the individual tiles on a mosaic, says David C. Schwartz, a professor of genetics and chemistry at the University of Wisconsin–Madison. To make his point, he brings his face close to the table where he sits - his mosaic for the purpose of illustration - and describes the details of each imaginary tile.
Ready, aim, fire! Cancer-targeting mechanism underlies promising UW–Madison spinoff
For all their lethality, cancer cells don't look much different from healthy cells, a simple fact that causes endless pain and suffering. Finding cancer cells that have spread and threaten to grow into metastatic tumors is often a life-and-death matter.
UW-Madison cancer research showcased in Wisconsin Public Television series
Next week, cancer research by University of Wisconsin–Madison scientists will be featured in a series of programs airing on Wisconsin Public Television (WPT).
Study reveals possible biological trigger for canine bone cancer
Researchers at the University of Wisconsin–Madison School of Veterinary Medicine (SVM) have identified the biological mechanism that may give some cancer cells the ability to form tumors in dogs. The recent study uncovered an association between the increased expression of a particular gene in tumor cells and more aggressive behavior in a form of canine bone cancer. It may also have implications for human cancers by detailing a new pathway for tumor formation.
UW to test ‘breakthrough’ pediatric leukemia treatment
A promising method of immunotherapy to treat children with relapsed acute lymphocytic leukemia (ALL) is opening at the University of Wisconsin Carbone Cancer Center and American Family Children's Hospital. The trial is open to relapsed/refractory pediatric ALL patients who have limited treatment options.
UW-Madison scientists find how many cancers may evade treatment
Xiaojun Tan, a graduate student in Richard A. Anderson’s lab at the University of Wisconsin–Madison, made an unexpected observation while studying the locations inside cells where the epidermal growth factor receptor, EGFR, can be found. His subsequent investigation revealed how cancer was evading treatment drugs: by sneaking through the cellular back door.
Company developing radio frequency technology to localize breast tumors
Breast cancer may inspire more public discussion, advocacy and charitable giving than almost any other disease besides HIV and AIDS. But people rarely talk about the specific experiences to which cancer patients are subjected.
With NIH New Innovator Award, engineer to study how ovarian cancer spreads
With approximately 22,000 diagnoses annually in the United States, ovarian cancer isn't among the most commonly occurring cancers. Yet, the mortality rate for women who have ovarian cancer hovers above 60 percent.
Faster, safer method zaps tumors with great success
When Kevin McSweeney was referred to UW Health last year for a tumor in his liver, he had already gone through six rounds of chemotherapy and 13 surgeries over ten years to treat his metastasized cancer.
New tumor-targeting agent images and treats variety of cancers
Scientists at the University of Wisconsin Carbone Cancer Center (UWCCC) report that a new class of tumor-targeting agents can seek out and find dozens of solid tumors, even illuminating brain cancer stem cells that resist current treatments.